American Century Companies’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.6M | Buy |
530,809
+68,638
| +15% | +$11.8M | 0.05% | 408 |
|
|
2025
Q1 | $72M | Buy |
462,171
+54,877
| +13% | +$8.55M | 0.04% | 446 |
|
|
2024
Q4 | $56.1M | Buy |
407,294
+60,548
| +17% | +$8.34M | 0.03% | 569 |
|
|
2024
Q3 | $51.8M | Buy |
346,746
+40,772
| +13% | +$6.09M | 0.03% | 595 |
|
|
2024
Q2 | $41.7M | Sell |
305,974
-167
| -0.1% | -$22.8K | 0.03% | 643 |
|
|
2024
Q1 | $46.3M | Sell |
306,141
-1,596
| -0.5% | -$241K | 0.03% | 589 |
|
|
2023
Q4 | $38.8M | Sell |
307,737
-21,537
| -7% | -$2.71M | 0.03% | 600 |
|
|
2023
Q3 | $30.8M | Sell |
329,274
-33,092
| -9% | -$3.1M | 0.02% | 635 |
|
|
2023
Q2 | $32.3M | Buy |
362,366
+5,729
| +2% | +$511K | 0.02% | 595 |
|
|
2023
Q1 | $36.9M | Buy |
356,637
+12,943
| +4% | +$1.34M | 0.03% | 520 |
|
|
2022
Q4 | $42M | Buy |
343,694
+1,094
| +0.3% | +$134K | 0.03% | 463 |
|
|
2022
Q3 | $35.4M | Buy |
342,600
+2,114
| +0.6% | +$218K | 0.03% | 479 |
|
|
2022
Q2 | $31.7M | Sell |
340,486
-12,360
| -4% | -$1.15M | 0.03% | 532 |
|
|
2022
Q1 | $41.4M | Buy |
352,846
+30,648
| +10% | +$3.6M | 0.03% | 490 |
|
|
2021
Q4 | $43.3M | Buy |
322,198
+45,865
| +17% | +$6.17M | 0.03% | 507 |
|
|
2021
Q3 | $44M | Buy |
276,333
+16,230
| +6% | +$2.59M | 0.03% | 483 |
|
|
2021
Q2 | $34.2M | Buy |
260,103
+60,720
| +30% | +$7.99M | 0.02% | 545 |
|
|
2021
Q1 | $25.7M | Buy |
+199,383
| New | +$25.7M | 0.02% | 591 |
|